1,2-Isoselenazol-3(2H)-one derivatives as NDM-1 inhibitors displaying synergistic antimicrobial effects with meropenem on NDM-1 producing clinical isolates
Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review
Projects
RIF: Development of a Colistin/Adjuvant Antimicrobial Regimen That Exhibits Low Toxicity and High Efficacy in Combating Multi-drug-resistant Bacterial Pathogens
CHEN, S., CHAN, K. F., LI, X. & LIAO, J.
30/06/19 → 28/02/23
Project: Research
